CLEVELAND, Ohio (October 20, 2026)—Premature menopause is associated with an increased risk of several long-term health problems due to estrogen deficiency. Cardiovascular disease (CVD) is one of those health risks. However, the underlying cardiometabolic causes are unclear. A new study suggests a possible connection with insulin levels. Results of the study will be presented at the 2026 Annual Meeting of The Menopause Society in San Diego, October 20-24, 2026.

CLEVELAND, Ohio (October 20, 2026)—The menopause transition is often associated with genital changes, sexual discomfort, and urinary issues—symptoms that collectively are known as the genitourinary syndrome of menopause (GSM). Hormone and nonhormone treatments are available to manage these symptoms. A new pilot study explores histologic changes after microablative fractional radiofrequency. Results of the study will be presented at the 2026 Annual Meeting of The Menopause Society in San Diego, October 20-24, 2026.

CLEVELAND, Ohio (October 20, 2026)—Turnover related to menopause has become a critical global socioeconomic challenge, affecting female career longevity and organizational productivity. A new study suggests that, although many employers have attempted to make special accommodations in the workplace, they fail to address a woman’s increased psychological burdens related to the menopause transition. Results of the study will be presented at the 2026 Annual Meeting of The Menopause Society in San Diego, October 20-24, 2026.

CLEVELAND, Ohio (October 20, 2026)—Regular physical activity results in numerous health benefits. It has been shown to improve sleep, lower blood pressure, and reduce anxiety, while also building muscle, strengthening bones, and helping to control weight. A new study suggests it may also reduce an array of bothersome symptoms during perimenopause. Results of the study will be presented at the 2026 Annual Meeting of The Menopause Society in San Diego October 20-24, 2026.

CLEVELAND, Ohio (October 20, 2026)—Postmenopausal women are at greater risk for multiple health issues, such as hip fractures and urinary tract infections (UTIs), due to estrogen loss. Vaginal estrogen is used to prevent recurrent UTIs, but a new study suggests its use may be associated with perioperative hip fracture complications, like UTIs. Results of the study will be presented at the 2026 Annual Meeting of The Menopause Society in San Diego October 20-24, 2026.

CLEVELAND, Ohio (October 20, 2026)—Migraines are estimated to affect 10% to 29% of women during the menopause transition, when migraines often worsen and become more frequent, especially during perimenopause. This is due to unpredictable estrogen drops. A new study suggests postmenopausal women using hormone therapy will experience more frequent, longer-lasting migraines. Results of the study will be presented at the 2026 Annual Meeting of The Menopause Society in San Diego October 20-24, 2026.

CLEVELAND, Ohio (October 20, 2026)—Hot flashes are the most frequent symptom of perimenopause and menopause, affecting 75% to 85% of women. In recent years, there has been a spike in the number of nonhormone options for managing hot flashes. A new study suggests that transdermal nitroglycerin may be an option. Results of the study will be presented at the 2026 Annual Meeting of The Menopause Society in San Diego October 20-24, 2026.

CLEVELAND, Ohio (October 20, 2026)­­ – Neurokinin receptor (NKR) antagonists are already widely used for treating menopausal hot flashes, representing a highly effective nonhormone treatment. A new study suggests they may also help breast cancer patients by limiting the spread of cancer cells and helping to prevent a recurring cancer diagnosis. Results of the study will be presented at the 2026 Annual Meeting of The Menopause Society in San Diego October 20-24, 2026.

CLEVELAND, Ohio (October 20, 2026)—Cognitive behavioral therapy (CBT) has proven effective in managing a number of menopause symptoms, including hot flashes, insomnia, depression, and sexual dysfunction. However, access remains limited. A new study suggests that virtual reality (VR) and artificial intelligence (AI) could be effective in delivering CBT interventions. Results of the study will be presented at the 2026 Annual Meeting of The Menopause Society in San Diego October 20-24, 2026.